Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.
about
Structure and functions of angiotensinogenDivergent mechanism regulating fluid intake and metabolism by the brain renin-angiotensin systemMolecular and Pathophysiological Features of Angiotensinogen: A Mini ReviewAblation of renin-expressing juxtaglomerular cells results in a distinct kidney phenotype.Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II.Cardiovascular consequences of genetic variation at -6/235 in human angiotensinogen using "humanized" gene-targeted mice.Collecting duct-specific knockout of renin attenuates angiotensin II-induced hypertension.Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient miceAndrogen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETSAntisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosisTransgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injuryCreation and characterization of a renin knockout rat.An androgen-inducible proximal tubule-specific Cre recombinase transgenic modelA possible interaction between systemic and renal angiotensinogen in the control of blood pressure.Preservation of intracellular renin expression is insufficient to compensate for genetic loss of secreted renin.Telemetric analysis of haemodynamic regulation during voluntary exercise training in mouse modelsMechanisms of impaired urinary concentrating ability in adult rats treated neonatally with enalapril.Angiotensin II Receptor Physiology Using Gene Targeting.Transgenic animal models for the functional analysis of vasoactive peptides.
P2860
Q26765070-CF9F0B79-ADF7-4153-975F-A57276EB985AQ27023126-48E015C1-10DC-4043-9AE2-830C7A1C0CD0Q28609735-9539DB2E-7DDA-40DC-9304-4951A0D10D31Q30311914-017BA183-F064-4D5F-B0B9-E16D30E09B3CQ33593068-327BBAEA-5254-4EDB-83FA-4626709710BFQ34222317-089FA032-192C-4A1D-B0CD-68310B9625DDQ34355942-F6D668B3-038E-4FB2-97E9-CDC812303575Q34433103-58DF33FC-325D-4FDE-AF08-CE51AADDAE3CQ34454880-797FD5FB-5E90-4B0A-A6E2-84231B7EFED6Q35086449-C08483BF-C13F-40ED-93CC-32339CD864A4Q35088385-D937301B-463D-41FF-A164-AD179360E374Q35628316-182E98D5-EECB-4750-B138-6C3095AE4A00Q36441725-2CD87E99-6B3A-41D7-8044-838C74A72E0DQ36646013-FAED1F18-C7F0-463F-A68C-308E20592EB8Q36764899-AF665CE6-BF5C-4037-A145-E2534C9CB634Q37440785-00C86E7C-CC7F-4AD2-AC59-A23CB434A826Q37709736-F75952A2-0DD9-4CCA-9B65-07181F6D953DQ51471225-6F3F2228-2205-4834-B9C4-CA8102B16A47Q52543165-7D205BB3-E41F-4315-B04F-862148DCA494Q52981348-B82DB8B9-094D-4B79-BE9F-EE3E33E9CBE7
P2860
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Complementation of reduced sur ...... d human angiotensinogen genes.
@en
Complementation of reduced sur ...... d human angiotensinogen genes.
@nl
type
label
Complementation of reduced sur ...... d human angiotensinogen genes.
@en
Complementation of reduced sur ...... d human angiotensinogen genes.
@nl
prefLabel
Complementation of reduced sur ...... d human angiotensinogen genes.
@en
Complementation of reduced sur ...... d human angiotensinogen genes.
@nl
P2093
P2860
P356
P1476
Complementation of reduced sur ...... d human angiotensinogen genes.
@en
P2093
P2860
P304
P356
10.1172/JCI119283
P407
P577
1997-03-01T00:00:00Z